Genetic Testing for Hereditary Cancer Risk

N/A

Recruiting

Led By Arun Banu, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial offers genetic testing and screening for women at risk for hereditary cancer to help prevent, detect, and personalize treatment.

Who is the study for?

This trial is for women scheduled for mammograms with Project VALET's mobile units. It aims to identify those at risk of hereditary cancers like ovarian, breast, and colorectal cancer by providing genetic screening and counseling.

What is being tested?

The study tests the effectiveness of using mobile mammography units to offer genetic testing and counseling services. The goal is to see if this approach helps in early detection or personalized treatment planning for hereditary cancers.

What are the potential side effects?

Since the interventions involve non-invasive procedures like genetic testing and counseling, there are minimal physical side effects expected. However, participants may experience emotional or psychological impacts from learning about their cancer risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Screening FormExperimental Treatment1 Intervention

Participants will complete a screening form to assess your risk of hereditary breast and colorectal cancers.

Group II: Genetic Testing and CounselingExperimental Treatment1 Intervention

Participants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing. The kit includes all standard paperwork and instructions for collecting the sample and shipping the kit back to the genetic testing company (Invitae).

0 / 1Eligibility criteria met